Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biodesix Inc (NQ: BDSX ) 1.740 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biodesix Inc < Previous 1 2 3 4 5 6 7 Next > Biodesix Announces Third Quarter 2023 Results and Highlights November 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023 October 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting October 03, 2023 From Biodesix, Inc. Via Business Wire Recap: Biodesix Q1 Earnings May 11, 2023 Via Benzinga Biodesix Earnings Perspective: Return On Capital Employed March 09, 2023 Via Benzinga Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer September 07, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in Two Upcoming Investor Conferences in September September 05, 2023 From Biodesix, Inc. Via Business Wire Kingstone Companies And 3 Other Stocks Under $2 Insiders Are Buying August 24, 2023 The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer August 22, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Second Quarter 2023 Results and Highlights August 07, 2023 From Biodesix, Inc. Via Business Wire Top 5 Health Care Stocks That May Crash In Q3 August 07, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference August 01, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023 July 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules July 12, 2023 From Biodesix, Inc. Via Business Wire Why Shares of CareDx Are Jumping Friday July 07, 2023 The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services. Via The Motley Fool 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 06, 2023 Via Benzinga Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services July 06, 2023 From Biodesix, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday July 06, 2023 It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday! Via InvestorPlace Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier June 27, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting June 01, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference May 31, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing May 25, 2023 From Biodesix, Inc. Via Business Wire Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors May 24, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference May 18, 2023 From Biodesix, Inc. Via Business Wire Biodesix Announces First Quarter 2023 Results and Highlights May 11, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023 April 27, 2023 From Biodesix, Inc. Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session March 15, 2023 Via Benzinga Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights March 06, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference February 28, 2023 From Biodesix, Inc. Via Business Wire Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 February 21, 2023 From Biodesix, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.